These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7788913)

  • 1. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
    Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
    Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
    Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
    Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
    Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
    Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1994 Nov; 90(5):2267-79. PubMed ID: 7955183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
    Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
    J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Hayashida K; Tanaka M; Morita H; Hayashi F; Inada T; Suzuki H; Sakamoto T; Katsuragawa M; Hibino H; Kambara H
    Heart Vessels; 2002 May; 16(4):137-45. PubMed ID: 12224784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
    Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
    Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome.
    Gershlick A; Brack MJ; More RS; Syndercombe-Court D; Balcon R
    Coron Artery Dis; 1993 Jan; 4(1):73-81. PubMed ID: 8269186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary restenosis: the cardiologist facing problems of definitions].
    Charron P; Montalescot G; Drobinski G; Grosgogeat Y; Thomas D
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):13-9. PubMed ID: 7646244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.
    Lablanche JM; Grollier G; Lusson JR; Bassand JP; Drobinski G; Bertrand B; Battaglia S; Desveaux B; Juillière Y; Juliard JM; Metzger JP; Coste P; Quiret JC; Dubois-Randé JL; Crochet PD; Letac B; Boschat J; Virot P; Finet G; Le Breton H; Livarek B; Leclercq F; Béard T; Giraud T; Bertrand ME
    Circulation; 1997 Jan; 95(1):83-9. PubMed ID: 8994421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty.
    Price JF; Mamode N; Smith FB; Woodburn KR; Rumley A; Lowe GD; Fowkes FG
    Eur J Vasc Endovasc Surg; 1997 Nov; 14(5):392-8. PubMed ID: 9413381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.